Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

Similar articles for PubMed (Select 14563743)

1.

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.

Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.

BMJ. 2003 Oct 18;327(7420):891.

2.

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.

Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.

Ann Allergy Asthma Immunol. 2004 Jun;92(6):641-8.

PMID:
15237766
3.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
4.

Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.

Lenney W, McKay AJ, Tudur Smith C, Williamson PR, James M, Price D; MASCOT Study Group.

Health Technol Assess. 2013 Feb;17(4):1-218. doi: 10.3310/hta17040.

6.

Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.

O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.

Ann Allergy Asthma Immunol. 2004 Dec;93(6):581-8.

PMID:
15609769
7.

Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.

Fogel RB, Rosario N, Aristizabal G, Loeys T, Noonan G, Gaile S, Smugar SS, Polos PG.

Ann Allergy Asthma Immunol. 2010 Jun;104(6):511-7. doi: 10.1016/j.anai.2009.12.011.

PMID:
20568384
8.
9.

Randomized comparison of strategies for reducing treatment in mild persistent asthma.

American Lung Association Asthma Clinical Research Centers, Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA.

N Engl J Med. 2007 May 17;356(20):2027-39. Erratum in: N Engl J Med. 2007 Aug 16;357(7):728.

10.

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.

Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65.

PMID:
10094216
11.

A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.

Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM; Challenge-Rescue Study Group.

Respir Med. 2004 Nov;98(11):1051-62.

PMID:
15526805
12.

Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.

O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.

Pharmacoeconomics. 2004;22(12):815-25.

PMID:
15294013
14.

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.

Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.

J Allergy Clin Immunol. 2000 Dec;106(6):1088-95. Erratum in: J Allergy Clin Immunol 2001 Apr;107(4):614.

PMID:
11112891
15.

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.

Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.

Pharmacoeconomics. 2002;20(13):909-18.

PMID:
12381242
16.

[A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].

Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.

Eur Ann Allergy Clin Immunol. 2003 Nov;35(9):356-62. French.

PMID:
14716965
17.
18.

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.

Fish JE, Israel E, Murray JJ, Emmett A, Boone R, Yancey SW, Rickard KA.

Chest. 2001 Aug;120(2):423-30.

PMID:
11502639
19.

Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.

Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.

Can Respir J. 1999 Jan-Feb;6(1):45-51.

PMID:
10202220
20.

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.

Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA; Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group.

Thorax. 2003 Mar;58(3):211-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk